Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial
BackgroundTumor invasion and metastasis are responsible for the majority of cancer-related deaths. The identification of molecules involved in these processes is crucial to design effective treatments that can halt the progression of cancer. To spread and metastasize, tumor cells must restructure th...
Main Authors: | Antonio Asensi-Cantó, Edith Rodríguez-Braun, Asunción Beltrán-Videla, Ana María Hurtado, Pablo Conesa-Zamora |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1238464/full |
Similar Items
-
Erratum: Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial
by: Frontiers Production Office
Published: (2024-04-01) -
Antitumoral Effects of Tricyclic Antidepressants: Beyond Neuropathic Pain Treatment
by: Antonio Asensi-Cantó, et al.
Published: (2022-07-01) -
Fascin-1: Updated biological functions and therapeutic implications in cancer biology
by: Chien-Hsiu Li, et al.
Published: (2022-01-01) -
Fascin in Gynecological Cancers: An Update of the Literature
by: Ishita Gupta, et al.
Published: (2021-11-01) -
Nuclear fascin regulates cancer cell survival
by: Campbell D Lawson, et al.
Published: (2022-08-01)